Monograph No. 036 / Herbals & Others
Herbals & Others
Glucosamine and Chondroitin: Benefits, Dosage, and Safety
Glucosamine and chondroitin are natural components of joint cartilage sold as dietary supplements for osteoarthritis, but NIH-reviewed evidence for symptom relief is inconsistent and expert guidelines disagree.
Glucosamine and chondroitin are natural components of joint cartilage sold as dietary supplements for osteoarthritis, but NIH-reviewed evidence for symptom relief is inconsistent and expert guidelines disagree.
What glucosamine and chondroitin is
Glucosamine and chondroitin are structural constituents of cartilage, the connective tissue that cushions joints. Glucosamine is a building block for glycosaminoglycans that form part of cartilage structure, and chondroitin is a cartilage component that helps it resist compression. In the United States they are sold as dietary supplements, alone or in combination; glucosamine is sold as glucosamine sulfate or glucosamine hydrochloride, and chondroitin as chondroitin sulfate. In some other countries certain preparations are sold as prescription drugs. They are among the most commonly used supplements by adults diagnosed with osteoarthritis.
What it does
- Glucosamine is a building block for glycosaminoglycans that are part of the structural matrix of cartilage
- Chondroitin is a component of cartilage that contributes to its resistance to compression
- Both are natural constituents of joint cartilage and connective tissue
- Taken as supplements they are studied for effects on joint pain and function in osteoarthritis, though benefit is not established
Intake and dosing
Glucosamine and Chondroitin is not an essential nutrient, so no Recommended Dietary Allowance or Tolerable Upper Intake Level has been set. Doses in studies vary widely. Because supplement doses are not standardised, discuss an appropriate amount with a clinician or pharmacist.
Deficiency and who is at risk
Not applicable. Glucosamine and chondroitin are not essential nutrients and have no defined dietary requirement, so there is no recognized deficiency state or deficiency syndrome. The body synthesizes glucosamine endogenously.
Groups more likely to fall short
- No recognized deficiency population; these are not essential nutrients
Who may need more
- Adults with knee or other osteoarthritis who choose to try a supplement, recognizing that NIH-reviewed evidence for benefit is inconsistent and major guidelines differ
- No one requires these for nutritional adequacy; they are not essential nutrients
- People with shellfish allergy should check the source, since glucosamine is often derived from shellfish
- People taking warfarin should consult a clinician before use because of bleeding risk
- People with diabetes or elevated blood sugar should monitor glucose, as glucosamine may raise blood glucose in some individuals
Food sources
Not obtained from ordinary foods in meaningful amounts. Supplemental glucosamine is typically manufactured from the shells of shellfish (or produced synthetically), and chondroitin is typically derived from animal cartilage. There is no established dietary food source.
Forms and absorption
Glucosamine is sold as glucosamine sulfate or glucosamine hydrochloride; chondroitin is sold as chondroitin sulfate. They are available separately or as a combination product. Some studies suggest results may differ between prescription/pharmaceutical-grade crystalline glucosamine sulfate formulations (sold in some countries) and over-the-counter formulations, though this may reflect differences in study quality or bias rather than proven product superiority. Product content can vary between brands.
Safety, excess and interactions
No major safety problems have been identified in large studies of glucosamine and chondroitin for osteoarthritis, and adverse events in trials such as GAIT were mild, infrequent, and evenly distributed versus placebo. However, glucosamine may increase blood glucose levels in some people, and both glucosamine and chondroitin have been associated with an increased risk of bleeding in people taking the anticoagulant warfarin. Glucosamine is often made from shellfish and may be a concern for people with shellfish allergy. Little is known about safety during pregnancy or breastfeeding. These supplements are not a cure for osteoarthritis; discuss use with a healthcare provider.
Too much
No major safety problems have been identified in large osteoarthritis studies. Reported effects at supplement doses are generally mild, infrequent, and similar to placebo, and may include gastrointestinal upset such as nausea, heartburn, or diarrhea. Glucosamine may raise blood glucose (sugar) levels in some people. No Tolerable Upper Intake Level has been established, and there is no established toxicity threshold.
Interactions to know
- Warfarin: glucosamine and chondroitin, alone or together, have been associated with an increased risk of bleeding in people taking the anticoagulant warfarin; INR should be monitored and a clinician consulted
- Antidiabetes medications / blood glucose: glucosamine may raise blood glucose levels in some people, which is relevant for people with diabetes or those on glucose-lowering therapy
How status is measured
Not routinely measured. There is no clinical laboratory marker for glucosamine or chondroitin status, and no deficiency state to test for.
What the evidence supports
We grade the strength of evidence behind each common reason people take glucosamine and chondroitin, mirroring how the NIH describes it.
Well established: glucosamine is a building block for cartilage glycosaminoglycans and chondroitin is a cartilage component that resists compression (NCCIH).
NCCIH states it remains uncertain whether they help knee osteoarthritis symptoms; studies are inconsistent and major guidelines conflict. The GAIT trial found no significant overall benefit versus placebo. ACR/AF (2019) and OARSI (2019) recommend against use; AAOS (2021) and ESCEO reach different conclusions.
Two large 2-year trials produced conflicting results; whether there is any effect on joint structure is uncertain (NCCIH).
One 6-month trial (162 participants) showed reduced hand pain and improved function; the 2019 ACR/AF guideline conditionally recommends chondroitin for hand osteoarthritis. Evidence is limited to few studies (NCCIH).
AAOS concluded moderate-strength evidence does not support glucosamine sulfate for hip osteoarthritis; the one high-quality trial found it no better than placebo (NCCIH).
Sources
- S1.gov verifiedNIH National Center for Complementary and Integrative Health (NCCIH)Glucosamine and Chondroitin for Osteoarthritis: What You Need To Knowwww.nccih.nih.gov/health/glucosamine-and-chondroitin
- S2.gov verifiedNew England Journal of Medicine (GAIT trial, NIH/NCCIH-funded)Glucosamine, Chondroitin Sulfate, and the Two in Combination for Painful Knee Osteoarthritis (Clegg et al., 2006)www.nejm.org/doi/full/10.1056/NEJMoa052771
- S3.gov verifiedU.S. National Library of Medicine / ClinicalTrials.govGlucosamine/Chondroitin Arthritis Intervention Trial (GAIT), NCT00032890clinicaltrials.gov/study/NCT00032890
Every figure on this page is quoted from the sources above. Science changes; we re-check and re-date pages as authorities update their guidance.